<?xml version="1.0" encoding="UTF-8"?>
<p id="Par20">Xiyanping can reduce inflammation in COVID-19 patients and improve symptoms such as cough, fever, and rales in the lungs [
 <xref ref-type="bibr" rid="CR29">29</xref>]. Discussed benefits include inhibiting viral replication and infection, inhibiting concurrent bacterial infections, improving the body's immunity, and improving liver function and cardiovascular damage. However, there are no reported clinical studies in the COVID-19 treatment. Xiyanping is recommended for treating patients in the progressive stage of COVID-19 (critical case) in the NHC guidelines [
 <xref ref-type="bibr" rid="CR6">6</xref>].
</p>
